Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 69.00
+3.20 (4.86%)
May 29, 2026, 1:30 PM CST
Tien Liang BioTech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 593.46 | 511.79 | 385.21 | 459.99 | 528.52 | 571.32 | |
Revenue Growth (YoY) | 54.57% | 32.86% | -16.26% | -12.97% | -7.49% | 32.53% |
Cost of Revenue | 256.14 | 223.86 | 155.29 | 173.85 | 191.98 | 233.04 |
Gross Profit | 337.32 | 287.94 | 229.91 | 286.15 | 336.55 | 338.28 |
Selling, General & Admin | 339.64 | 299.5 | 226.84 | 266 | 276.86 | 294.14 |
Research & Development | 4.38 | 4.58 | 2.48 | 1.28 | 1.4 | 1.2 |
Operating Expenses | 344.02 | 304.08 | 229.32 | 267.27 | 278.26 | 295.33 |
Operating Income | -6.7 | -16.14 | 0.59 | 18.87 | 58.29 | 42.95 |
Interest Expense | -11.83 | -11.13 | -3.08 | -2.08 | -1.77 | -1.85 |
Interest & Investment Income | 28.46 | 25.58 | 4.83 | 0.6 | 0.14 | 0.03 |
Currency Exchange Gain (Loss) | -9.89 | -9.89 | 6.16 | 0.1 | -0.45 | -0.06 |
Other Non Operating Income (Expenses) | 5.62 | -0.22 | 2.35 | 0.35 | 3.09 | 7.71 |
EBT Excluding Unusual Items | 5.66 | -11.8 | 10.84 | 17.84 | 59.3 | 48.78 |
Gain (Loss) on Sale of Investments | - | - | 2.93 | - | - | - |
Gain (Loss) on Sale of Assets | 0.05 | 0.05 | -0.68 | 0.57 | 0.03 | - |
Pretax Income | 5.71 | -11.75 | 13.1 | 18.42 | 59.33 | 48.78 |
Income Tax Expense | -0.64 | -1.5 | 1.4 | 0.68 | -0.15 | 2.18 |
Earnings From Continuing Operations | 6.35 | -10.25 | 11.7 | 17.73 | 59.48 | 46.61 |
Net Income | 6.35 | -10.25 | 11.7 | 17.73 | 59.48 | 46.61 |
Net Income to Common | 6.35 | -10.25 | 11.7 | 17.73 | 59.48 | 46.61 |
Net Income Growth | -70.84% | - | -34.04% | -70.19% | 27.63% | - |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Change (YoY) | -0.01% | -0.01% | -0.04% | 0.01% | 0.05% | - |
EPS (Basic) | 0.14 | -0.22 | 0.26 | 0.39 | 1.30 | 1.02 |
EPS (Diluted) | 0.14 | -0.22 | 0.26 | 0.39 | 1.30 | 1.02 |
EPS Growth | -70.84% | - | -34.04% | -70.19% | 27.63% | - |
Free Cash Flow | -16.14 | -3.96 | 44.61 | 64.71 | 20.87 | 44.61 |
Free Cash Flow Per Share | -0.35 | -0.09 | 0.97 | 1.41 | 0.46 | 0.97 |
Dividend Per Share | - | - | - | 0.500 | - | - |
Gross Margin | 56.84% | 56.26% | 59.69% | 62.21% | 63.68% | 59.21% |
Operating Margin | -1.13% | -3.15% | 0.15% | 4.10% | 11.03% | 7.52% |
Profit Margin | 1.07% | -2.00% | 3.04% | 3.85% | 11.25% | 8.16% |
Free Cash Flow Margin | -2.72% | -0.77% | 11.58% | 14.07% | 3.95% | 7.81% |
EBITDA | 3.45 | -6.58 | 9.25 | 28.82 | 68.28 | 54.15 |
EBITDA Margin | 0.58% | -1.29% | 2.40% | 6.26% | 12.92% | 9.48% |
D&A For EBITDA | 10.15 | 9.57 | 8.66 | 9.94 | 10 | 11.21 |
EBIT | -6.7 | -16.14 | 0.59 | 18.87 | 58.29 | 42.95 |
EBIT Margin | -1.13% | -3.15% | 0.15% | 4.10% | 11.03% | 7.52% |
Effective Tax Rate | - | - | 10.70% | 3.71% | - | 4.46% |